Abstract:Objective: Vertical Sleeve Gastrectomy (VSG) is one of the most efficacious treatments for obesity and its comorbidities. Although a range of evidence suggests that alterations of the microbiota in the distal gut following VSG are pivotal to these metabolic improvements, the effect of surgery to alter the microbiota of the proximal intestine and its effect on host physiology remain largely unknown. As the main bacteria in the upper small intestine, Lactobacillus subspecies have been appreciated as important regulators of gut function. These bacteria also regulate intestinal Hypoxia- Inducible Factor 2a (HIF2a) signaling that plays an integral role in gut physiology and iron absorption. In the present study, we sought to determine the impact of VSG on Lactobacillus spp. in the small intestine and potential downstream impacts of Lactobacillus spp. on HIF2a, specifically in the duodenum. Methods: To determine the effects of VSG on the microbiota and HIF2a signaling in the duodenum, VSG surgeries were performed on dietinduced obese mice. To further probe the relationship between Lactobacillus spp. and HIF2a signaling in the duodenum, we applied a customized high-fat but iron-deficient diet on mice to increase duodenal HIF2a signaling and determined alterations of gut bacteria. To explore the causal role of Lactobacillus spp. in duodenal HIF2a signaling activation, we chronically administered probiotics containing Lactobacillus spp. to high-fat-fed obese mice. Lastly, we studied the effect of lactate, the major metabolite of Lactobacilli, on HIF2a in ex vivo duodenal organoids. Results: There were pronounced increases in the abundance of Lactobacillus spp. in samples isolated from duodenal epithelium in VSGoperated mice as compared to sham-operated mice. This was accompanied by an increase in the expression of genes that are targets of HIF2a in the duodenum of VSG-treated mice. Activating HIF2a signaling with a high-fat but iron-deficient diet resulted in weight loss, improvements in glucose regulation, and increased Lactobacillus spp. richness in the duodenum as compared to mice on an iron-replete diet. Chronic administration of probiotics containing Lactobacillus spp. not only increased HIF2a signaling in the duodenum such as occurs after VSG but also resulted in reduced weight gain and improved glucose tolerance in high-fat-fed mice. Furthermore, lactate was able to activate HIF2a in ex vivo duodenal organoids. Conclusions: These results support a model whereby VSG increases duodenal Lactobacillus richness and potentially stimulates intestinal HIF2a signaling via increased lactate production. m 2022 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Intestinal-derived FGF15 protects against deleterious effects of vertical sleeve gastrectomy in mice

Effects of intestine-specific deletion of FGF15 on the development of fatty liver disease with vertical sleeve gastrectomy

Vertical Sleeve Gastrectomy Triggers Fast Β-Cell Recovery Upon Overt Diabetes

Vertical Sleeve Gastrectomy Activates Gpbar-1/Tgr5 to Sustain Weight Loss, Improve Fatty Liver, and Remit Insulin Resistance in Mice

Intestinal epithelial adaptations to vertical sleeve gastrectomy defined at single-cell resolution

Targeting FXR and FGF19 to Treat Metabolic Diseases—Lessons Learned From Bariatric Surgery

Vertical sleeve gastrectomy confers metabolic improvements by reducing intestinal bile acids and lipid absorption in mice

Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor

Effect of oligofructose on resistance to postoperative high-fat diet-induced damage of metabolism in diabetic rats after sleeve gastrectomy

Vertical Sleeve Gastrectomy Offers Protection against Disturbed Flow-Induced Atherosclerosis in High-Fat Diet-Fed Mice

Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy

RYGB Is More Effective than VSG at Protecting Mice from Prolonged High-Fat Diet Exposure: An Occasion to Roll Up Our Sleeves?

CYP8B1 Downregulation Mediates the Metabolic Effects of Vertical Sleeve Gastrectomy in Mice.

Insulin Resistance, Microbiota, and Fat Distribution Changes by a New Model of Vertical Sleeve Gastrectomy in Obese Rats

Vertical sleeve gastrectomy increases duodenal Lactobacillus spp. richness associated with the activation of intestinal HIF2a signaling and metabolic benefits

Effects of Vitamin D Deficiency on the Improvement of Metabolic Disorders in Obese Mice after Vertical Sleeve Gastrectomy.

Vertical sleeve gastrectomy reduces blood pressure and hypothalamic endoplasmic reticulum stress in mice

Somatostatin: a possible mediator of the long-term effects of experimental vertical gastrectomy on glucose metabolism in rats?

IFN-γ Secretion in Gut of Ob/Ob Mice after Vertical Sleeve Gastrectomy and Its Function in Weight Loss Mechanism

Sleeve Gastrectomy Preferentially Increases GDF15 Plasma Levels in Patients With Obesity but Without Metabolic Syndrome

Roux-en-Y Gastric Bypass Surgery is Effective in Fibroblast Growth Factor-21 Deficient Mice